...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: got this & sent a response/follow up minutes before …

fuzzyjr - Looks like there are others of the same mindset as you that are taking this opportunity to do some tax loss selling now that plan to repurchase toward the end of January. If this situation continues the way it has for the last 2 years it doesn't look like there is much risk in that strategy. I'm to chicken to do that in case he actually does pull a rabbit out of his hat.

Merry Christmas and a prosperous New Year to all that follow these little....gems.

tada 

Share
New Message
Please login to post a reply